Published on 28th April 2009
Nick Adams, Chief Executive of Bioquell PLC informed the Company that he had exercised 80,000 options over Shares. Mark Bodeker, Chief Operating Officer, informed the Company that he had exercised 80,000 options over Shares.
Published on 27th March 2009
Bioquell PLC announces that Nicholas Adams, Chief Executive, and Mark Bodeker, Chief Operating Officer and Finance Director, have been awarded options (“Options”), with vesting preconditions, over ordinary Bioquell shares.
Published on 24th March 2009
Bioquell PLC announces its results for the year ended 31 December, 2008.
Published on 27th February 2009
Bioquell has won a prestigious award from the Department of Health and NHS Purchasing and Supply Agency (PASA) in recognition of its Hydrogen Peroxide Vapour (HPV) decontamination technology, offering the greatest contribution in controlling Clostridium difficile.